Analyst Ratings for Cohen & Steers Inc. (CNS)Updated: 2017-07-27
Shares of Cohen & Steers Inc. (NYSE:CNS) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for CNS last month.
3 analysts declared CNS a buy, 0 gave an overweight rating, 3 gave a hold rating, 1 issued an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
A number of analysts gave price targets for CNS. The most optimistic analyst gave a price target of 46, which equates to a potential upside of 10.84 percent. The most pessimistic analyst gave a price target of 35, implying a possible loss of -15.66 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
Analysts have revised their earnings estimates upwards for this quarter, by about 4.04 percent on average, compared to last month. That number becomes 4.04 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 2.82 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 2.82 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Over the same time period, 3 analysts revised their FY earnings estimates upwards, compared to 0 analysts that revised their FY estimates downwards.
Analysts estimate earnings of CNS to grow at a rate of -3.87 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of CNS is -5.2.
In the last 52-weeks, CNS has achieved a high of 43.54 and a low of 33.16. Today's price is 25.15 percent above the 52-week low, and 4.69 percent lower than its 52-week high. CNS has a price/earnings ratio of 20.13. Investors typically compare the P/E ratio to a company's peers in the industry. The CNS value stock report compares CNS to some of its peers using value stock charts. The stock has a market capitalization of $1.94 billion. CNS will post this quarters earnings in days, on 0000-00-00.